FT News Briefing
Final US presidential debate, FDA approves remdesivir, Intel data hit by pandemic
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Donald Trump and his Democratic challenger, Joe Biden, clashed over issues from the pandemic to foreign policy in their final presidential election debate. Then, the FT’s Demetri Sevastopulo will explain why local races in Texas and around the US could dictate the political make-up of the country for years to come. Plus, Gilead has received the first US regulatory approval for a Covid-19 drug, and Intel reported a decline in data centre revenues and said its earnings fell by nearly a quarter from a year ago due to the pandemic.
Donald Trump and Joe Biden clash over coronavirus in final debate
https://www.ft.com/content/bef48683-9bde-4ac2-8906-797779593b22
Gilead secures FDA approval for remdesivir
https://www.ft.com/content/07a321de-109b-46aa-99bc-f884e0ed7703
Hosted on Acast. See acast.com/privacy for more information.